SCHEMBL5524906

SCHEMBL5524906

CCc1ccc(C(=O)N(C)OC)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16711681 0.86 P4HTM (0.38) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL31003087 0.86 POLB (0.40) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL4814824 0.85 NFKB1 (0.62) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL10272733 0.83 MAPT (0.46) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL29417119 0.82 MLYCD (0.40) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL30713019 0.82 HIF1A (0.44) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL18809992 0.82 MLYCD (0.40) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL16317926 0.79 MAPT (0.49) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL568798 0.79 MAPK1 (0.39) L3MBTL1KDM4EKMT2AMEN1POLB
SCHEMBL11929579 0.79 TDP1 (0.40) L3MBTL1MAPTKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 L3MBTL1 3071/4885MAPT 4851/4885KDM4E 2495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.